Abnormality of fibrinolysis Reduced euglobulin clot lysis time 2016-01-21T17:29:51Z This term has been requested and created by members of the BRIDGE consortium UMLS:C4280701 Abnormally decreased length of time required for an in vitro clot to dissolve in the absence of the normal plasmin inhibitors. This test is a clinical assay used to measure fibrinolysis. The euglobulin fraction of plasma is precipitated and used to form clot by addition of thrombin; after clot forms the rate of clot breakdown (fibrinolysis) can be monitored.